Introduction: Myocardial infarction is one of the most common causes of death worldwide. Venous thrombolytic therapy is one of the important treatments in the acute phase of this disease. Although benefits of thrombolytic therapy is approved in patients aged less than 75 years, beneficial effects of this treatment in old patients is controversial. The aim of our study was evaluation of venous streptokinase side effect in old patients. Methods: This cross-sectional descriptive study was conducted on 100 patients with acute myocardial infarction that received venous streptokinase ; Then, blood, cardiovascular and allergic side effects were evaluated. The data were analyzed, using SPSS.

